Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by VIVEK SUBBIAH and SIREESHA YEDURURI.
VIVEK SUBBIAH
Connection Strength
0.567
SIREESHA YEDURURI
  1. Multi-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgery. Oncoscience. 2023; 10:38-43.
    View in: PubMed
    Score: 0.228
  2. Exceptional Responses to Selpercatinib in RET Fusion-Driven Metastatic Pancreatic Cancer. JCO Precis Oncol. 2023 09; 7:e2300252.
    View in: PubMed
    Score: 0.227
  3. Efficacy and Safety of Selective RET Inhibitors in Patients with Advanced Hereditary Medullary Thyroid Carcinoma. Thyroid. 2024 Dec 04.
    View in: PubMed
    Score: 0.062
  4. Emergence of mTOR mutation as an acquired resistance mechanism to AKT inhibition, and subsequent response to mTORC1/2 inhibition. NPJ Precis Oncol. 2021 Dec 01; 5(1):99.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.